Sfoglia per Autore
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction.
2014-01-01 Zamperini, C; Dreassi, E; Vignaroli, G; Radi, M; Dragoni, S; Schenone, Silvia; Musumeci, Francesca; Valoti, M; Antiochia, R; Botta, M.
6-Substituted pyrazolo[3,4-d]pyrimidines: new promising compounds in the fight against Neuroblastoma
2014-01-01 Musumeci, F.; Desogus, A.; Schenone, S.; Brullo, C.; Fallacara, A. L.; Tintori, C.; Dreassi, E.; Zamperini, C.; Maga, G.; Angelucci, A.; Botta,
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold
2014-01-01 Ortuso, F; Amato, R; Artese, A; D'Antona, L; Costa, G; Talarico, C; Gigliotti, F; Bianco, C; Trapasso, F; Schenone, Silvia; Musumeci, Francesca; Botta, L; Perrotti, N; Alcaro, S.
Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies
2014-01-01 Schenone, Silvia; Radi, M; Musumeci, Francesca; Brullo, Chiara; Botta, M.
Click Chemistry, A Potent Tool in Medicinal Sciences
2015-01-01 Musumeci, Francesca; Schenone, Silvia; Desogus, Andrea; Nieddu, E.; Deodato, D.; Botta, L.
Synthesis of pyrazolo[3,4-d]pyrimidine derivatives active in a preclinical glioblastoma model.
2015-01-01 Musumeci, F.; Sanna, M.; Desogus, A.; Brullo, C.; Tintori, C.; Botta, M.; Indovina, P.; Giordano, A.; Schenone, S.
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma.
2015-01-01 Tintori, C; Fallacara, Al; Radi, M; Zamperini, C; Dreassi, E; Crespan, E; Maga, G; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Richters, A; Gasparrini, F; Angelucci, A; Festuccia, C; Delle Monache, S; Rauh, D; Botta, M.
SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation
2015-01-01 D'Antona, Lucia; Amato, Rosario; Talarico, Cristina; Ortuso, Francesco; Menniti, Miranda; Dattilo, Vincenzo; Iuliano, Rodolfo; Gigliotti, Francesco; Artese, Anna; Costa, Giosuè; Schenone, Silvia; Musumeci, Francesca; Abbruzzese, Claudia; Botta, Lorenzo; Trapasso, Francesco; Alcaro, Stefano; Paggi, Marco G.; Perrotti, Nicola
Analogs, formulations and derivatives of imatinib: A patent review
2015-01-01 Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica
Hck inhibitors as potential therapeutic agents in cancer and HIV infection
2015-01-01 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Desogus, Andrea; Botta, L.; Tintori, C.
Bcr-Abl tyrosine kinase inhibitors: A patent review
2015-01-01 Desogus, Andrea; Schenone, Silvia; Brullo, Chiara; Tintori, Cristina; Musumeci, Francesca
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors
2015-01-01 Tintori, Cristina; La Sala, Giuseppina; Vignaroli, Giulia; Botta, Lorenzo; Fallacara, Anna Lucia; Falchi, Federico; Radi, Marco; Zamperini, Claudio; Dreassi, Elena; Dello Iacono, Lucia; Orioli, Donata; Biamonti, Giuseppe; Garbelli, Mirko; Lossani, Andrea; Gasparrini, Francesca; Tuccinardi, Tiziano; Laurenzana, Ilaria; Angelucci, Adriano; Maga, Giovanni; Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Desogus, Andrea; Crespan, Emmanuele; Botta, Maurizio
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells
2016-01-01 Talarico, Cristina; Dattilo, Vincenzo; D’Antona, Lucia; Barone, Agnese; Amodio, Nicola; Belviso, Stefania; Musumeci, Francesca; Abbruzzese, Claudia; Bianco, Cataldo; Trapasso, Francesco; Schenone, Silvia; Alcaro, Stefano; Ortuso, Francesco; Florio, Tullio; Paggi, Marco G.; Perrotti, Nicola; Amato, Rosario
Synthesis of heterocyclic compounds to be tested as potentiators or correctors of mutant CFTR in cystic fibrosis
2016-01-01 Musumeci, F.; Sanna, M.; Giacchello, I.; Mazzei, M.; Schenone, S.
A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutant
2016-01-01 Radi, Marco; Schneider, Ralf; Fallacara, Anna Lucia; Botta, Lorenzo; Crespan, Emmanuele; Tintori, Cristina; Maga, Giovanni; Kissova, Miroslava; Calgani, Alessia; Richters, André; Musumeci, Francesca; Rauh, Daniel; Schenone, Silvia
Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809
2017-01-01 Marengo, Barbara; Speciale, Andrea; Senatore, Lisa; Garibaldi, Silvano; Musumeci, Francesca; Nieddu, Erika; Pollarolo, Benedetta; Pronzato, MARIA ADELAIDE; Schenone, Silvia; Mazzei, Mauro; Domenicotti, CINZIA MARIA
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma
2017-01-01 Musumeci, F; Fallacara, Al; Brullo, C; Grossi, G; Botta, L; Calandro, P; Chiariello, M; Kissova, M; Crespan, E; Maga, G; Schenone, S.
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme
2017-01-01 Abbruzzese, Claudia; Catalogna, Giada; Gallo, Enzo; di Martino, Simona; Mileo, Anna M.; Carosi, Mariantonia; Dattilo, Vincenzo; Schenone, Silvia; Musumeci, Francesca; Lavia, Patrizia; Perrotti, Nicola; Amato, Rosario; Paggi, Marco G.
Insight into Fyn and SGK1 kinases as new targets in medicinal chemistry: design and synthesis of pyrazolo[3,4-d]pyrimidine libraries
2017-01-01 Musumeci, F.; Schenone, S.; Fallacara, A. L.; Trist, I.; Perrotti, N.; Alcaro, S.; Ortuso, F.; Maga, G.
Synthesis of a new generation of pyrazolo[3,4-d]pyrimidine as SGK-1 inhibitors.
2017-01-01 Greco, C.; Sanna, M.; Musumeci, F.; Giacchello, I.; Perrotti, N.; Alcaro, S.; Ortuso, F.; Schenone, S.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction. | 1-gen-2014 | Zamperini, C; Dreassi, E; Vignaroli, G; Radi, M; Dragoni, S; Schenone, Silvia; Musumeci, Francesca; Valoti, M; Antiochia, R; Botta, M. | |
6-Substituted pyrazolo[3,4-d]pyrimidines: new promising compounds in the fight against Neuroblastoma | 1-gen-2014 | Musumeci, F.; Desogus, A.; Schenone, S.; Brullo, C.; Fallacara, A. L.; Tintori, C.; Dreassi, E.; Zamperini, C.; Maga, G.; Angelucci, A.; Botta, | |
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold | 1-gen-2014 | Ortuso, F; Amato, R; Artese, A; D'Antona, L; Costa, G; Talarico, C; Gigliotti, F; Bianco, C; Trapasso, F; Schenone, Silvia; Musumeci, Francesca; Botta, L; Perrotti, N; Alcaro, S. | |
Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies | 1-gen-2014 | Schenone, Silvia; Radi, M; Musumeci, Francesca; Brullo, Chiara; Botta, M. | |
Click Chemistry, A Potent Tool in Medicinal Sciences | 1-gen-2015 | Musumeci, Francesca; Schenone, Silvia; Desogus, Andrea; Nieddu, E.; Deodato, D.; Botta, L. | |
Synthesis of pyrazolo[3,4-d]pyrimidine derivatives active in a preclinical glioblastoma model. | 1-gen-2015 | Musumeci, F.; Sanna, M.; Desogus, A.; Brullo, C.; Tintori, C.; Botta, M.; Indovina, P.; Giordano, A.; Schenone, S. | |
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma. | 1-gen-2015 | Tintori, C; Fallacara, Al; Radi, M; Zamperini, C; Dreassi, E; Crespan, E; Maga, G; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Richters, A; Gasparrini, F; Angelucci, A; Festuccia, C; Delle Monache, S; Rauh, D; Botta, M. | |
SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation | 1-gen-2015 | D'Antona, Lucia; Amato, Rosario; Talarico, Cristina; Ortuso, Francesco; Menniti, Miranda; Dattilo, Vincenzo; Iuliano, Rodolfo; Gigliotti, Francesco; Artese, Anna; Costa, Giosuè; Schenone, Silvia; Musumeci, Francesca; Abbruzzese, Claudia; Botta, Lorenzo; Trapasso, Francesco; Alcaro, Stefano; Paggi, Marco G.; Perrotti, Nicola | |
Analogs, formulations and derivatives of imatinib: A patent review | 1-gen-2015 | Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica | |
Hck inhibitors as potential therapeutic agents in cancer and HIV infection | 1-gen-2015 | Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Desogus, Andrea; Botta, L.; Tintori, C. | |
Bcr-Abl tyrosine kinase inhibitors: A patent review | 1-gen-2015 | Desogus, Andrea; Schenone, Silvia; Brullo, Chiara; Tintori, Cristina; Musumeci, Francesca | |
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors | 1-gen-2015 | Tintori, Cristina; La Sala, Giuseppina; Vignaroli, Giulia; Botta, Lorenzo; Fallacara, Anna Lucia; Falchi, Federico; Radi, Marco; Zamperini, Claudio; Dreassi, Elena; Dello Iacono, Lucia; Orioli, Donata; Biamonti, Giuseppe; Garbelli, Mirko; Lossani, Andrea; Gasparrini, Francesca; Tuccinardi, Tiziano; Laurenzana, Ilaria; Angelucci, Adriano; Maga, Giovanni; Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Desogus, Andrea; Crespan, Emmanuele; Botta, Maurizio | |
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells | 1-gen-2016 | Talarico, Cristina; Dattilo, Vincenzo; D’Antona, Lucia; Barone, Agnese; Amodio, Nicola; Belviso, Stefania; Musumeci, Francesca; Abbruzzese, Claudia; Bianco, Cataldo; Trapasso, Francesco; Schenone, Silvia; Alcaro, Stefano; Ortuso, Francesco; Florio, Tullio; Paggi, Marco G.; Perrotti, Nicola; Amato, Rosario | |
Synthesis of heterocyclic compounds to be tested as potentiators or correctors of mutant CFTR in cystic fibrosis | 1-gen-2016 | Musumeci, F.; Sanna, M.; Giacchello, I.; Mazzei, M.; Schenone, S. | |
A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutant | 1-gen-2016 | Radi, Marco; Schneider, Ralf; Fallacara, Anna Lucia; Botta, Lorenzo; Crespan, Emmanuele; Tintori, Cristina; Maga, Giovanni; Kissova, Miroslava; Calgani, Alessia; Richters, André; Musumeci, Francesca; Rauh, Daniel; Schenone, Silvia | |
Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809 | 1-gen-2017 | Marengo, Barbara; Speciale, Andrea; Senatore, Lisa; Garibaldi, Silvano; Musumeci, Francesca; Nieddu, Erika; Pollarolo, Benedetta; Pronzato, MARIA ADELAIDE; Schenone, Silvia; Mazzei, Mauro; Domenicotti, CINZIA MARIA | |
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma | 1-gen-2017 | Musumeci, F; Fallacara, Al; Brullo, C; Grossi, G; Botta, L; Calandro, P; Chiariello, M; Kissova, M; Crespan, E; Maga, G; Schenone, S. | |
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme | 1-gen-2017 | Abbruzzese, Claudia; Catalogna, Giada; Gallo, Enzo; di Martino, Simona; Mileo, Anna M.; Carosi, Mariantonia; Dattilo, Vincenzo; Schenone, Silvia; Musumeci, Francesca; Lavia, Patrizia; Perrotti, Nicola; Amato, Rosario; Paggi, Marco G. | |
Insight into Fyn and SGK1 kinases as new targets in medicinal chemistry: design and synthesis of pyrazolo[3,4-d]pyrimidine libraries | 1-gen-2017 | Musumeci, F.; Schenone, S.; Fallacara, A. L.; Trist, I.; Perrotti, N.; Alcaro, S.; Ortuso, F.; Maga, G. | |
Synthesis of a new generation of pyrazolo[3,4-d]pyrimidine as SGK-1 inhibitors. | 1-gen-2017 | Greco, C.; Sanna, M.; Musumeci, F.; Giacchello, I.; Perrotti, N.; Alcaro, S.; Ortuso, F.; Schenone, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile